NCT03508765已完成不适用
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 4
- 主要终点
- Changes in regional brain volume and functional connectivity when baseline and follow-up MRIs are compared.
研究概览
简要总结
The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with multiple myeloma and in complete, partial or very good partial remission at enrollment as per standard International Myeloma Working Group Criteria
- •Scheduled to have high-dose chemotherapy and ASCT
- •Age 60 - 75 years at study entry
- •In the judgment of the consenting professional, fluent and able to communicate well enough in English to complete the study assessments and provide informed consent.
- •Patients who report that English is not their primary language will be asked the US Census English proficiency question "How well do you speak English" and the answer "very well" will be required
排除标准
- •With signs and/or symptoms of central nervous system cancers (e.g., tumors, metastases, leptomeningial disease) as determined by their physician, medical records, or by a brain MRI, either at the time of enrollment or during the study period
- •With current diagnosis of major Axis I psychiatric disorder (DSM-IV), major depression, bipolar disorder, or schizophrenia, as per medical records or patient report
- •As per patient report or as confirmed by the medical record, if the patient is taking anti-depression or anti-anxiety medication, < 2 months on these medications or a change in the prescribed dose in the past 2 months
- •With history of a neurological disorder, neurodegenerative disease, or traumatic brain injury with loss of consciousness (>60 minutes), as per medical records or patient report
- •With a history of another cancer, except for non-melanoma skin cancer, as per medical records or patient report
- •With current substance abuse and/or history of substance abuse, as per medical records or patient report
- •With evidence of visual or auditory impairment that would preclude completion of the assessments, as per medical records or patient report
- •With contraindications to MRI examinations as per standard screening guidelines used in the Department of Radiology (i.e., ferromagnetic material or implants, pacemakers or defibrillators, stents, claustrophobia)
结局指标
主要结局
Changes in regional brain volume and functional connectivity when baseline and follow-up MRIs are compared.
时间窗: up to 4 months following chemotherapy and ASCT
Changes in neurocognitive functions in older participants with Multiple Myeloma following high-dose (HD) chemotherapy and autologous stem cell transplantation (ASCT) assessed by initial and follow-up neurocognitive evaluation
时间窗: up to 4 months following chemotherapy and ASCT
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
招募中
不适用
Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T TherapyLymphoma Receiving CAR-T TherapyNCT04107285Memorial Sloan Kettering Cancer Center120
Unknown
不适用
Confusion in the Elderly After Colon SurgeryConfusionInflammationAcute Phase ReactionSurgeryDeliriumNCT01623297New York Hospital Queens52
招募中
不适用
Cerebral and Cognitive Impact of Professional Soccer PracticeTraumatic Chronic EncephalopathyNCT04903015University Hospital, Strasbourg, France80
已完成
不适用
The Patients' Experience After Stem Cell TransplantStem Cell Transplant ComplicationsNCT03454568University of Nebraska110
尚未招募
不适用
Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell TransplantationHematopoietic Stem Cell TransplantationNCT06484049Institute of Hematology & Blood Diseases Hospital, China20